• Reset

A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, Leer mas
EfficACy of Spartalizumab acROss multiPle cancer-types in patients with PD1-high mRNA expressing tumOrs defined by Leer mas
SOLTI Molecular screening platform: a Pilot Study to implement personalized therapy for patients with advanced Leer mas
A randomised, multi-centre, open-label, phase III study of adjuvant lapatinib, trastuzumab, their sequence and their Leer mas
A randomized multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus Leer mas
A Phase II study of Adjuvant PALbociclib as an Alternative to CHemotherapy in Elderly patientS Leer mas
Targeting the PAM50 HER2-enriched phenotype with enzalutamide in hormone receptor-positive/HER2-negative metastatic breast cancer Leer mas
A Phase II clinical trial targeting estrogen receptor negative or PAM50 non-luminal disease with Atezolizumab Leer mas
Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. The AURORA PROGRAM Leer mas